[1]
Białek, J. et al. 2023. Teplizumab - current state of knowledge on the effects of teplizumab in preventing the development of type 1 diabetes in people at risk. Journal of Education, Health and Sport. 44, 1 (Aug. 2023), 288–299. DOI:https://doi.org/10.12775/JEHS.2023.44.01.018.